A Johns Hopkins team has developed a gene editing approach that could make the treatment of sickle cell disease shorter and less risky, relieving some of the burden on patients
Hopkins researchers develop a "one-stop shop" capsule for diagnosing and treating Barrett's esophagus, a condition known to be a precursor to esophageal cancer